G
Giuseppe Querques
Researcher at Vita-Salute San Raffaele University
Publications - 642
Citations - 12285
Giuseppe Querques is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Macular degeneration & Fluorescein angiography. The author has an hindex of 49, co-authored 573 publications receiving 9281 citations. Previous affiliations of Giuseppe Querques include University of Foggia & Università telematica San Raffaele.
Papers
More filters
Journal ArticleDOI
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group
Richard F. Spaide,Glenn J. Jaffe,David Sarraf,K. Bailey Freund,Srinivas R. Sadda,Giovanni Staurenghi,Nadia K. Waheed,Usha Chakravarthy,Philip J. Rosenfeld,Frank G. Holz,Eric H. Souied,Salomon Y. Cohen,Giuseppe Querques,Kyoko Ohno-Matsui,David S. Boyer,Alain Gaudric,Barbara A Blodi,Caroline R. Baumal,Xiaoxin Li,Gabriel Coscas,Alexander J. Brucker,Lawrence J. Singerman,Phil Luthert,Steffen Schmitz-Valckenberg,Ursula Schmidt-Erfurth,Hans E. Grossniklaus,David J. Wilson,Robyn H. Guymer,Lawrence A. Yannuzzi,Emily Y. Chew,Karl G. Csaky,Jordi Monés,Daniel Pauleikhoff,Ramin Tadayoni,James G. Fujimoto +34 more
TL;DR: The study group suggests that the consensus standards outlined in this article be used in future reported studies of neovascular AMD and clinical practice.
Journal ArticleDOI
Central serous chorioretinopathy: Towards an evidence-based treatment guideline
Thomas J. van Rijssen,Elon H. C. van Dijk,Suzanne Yzer,Kyoko Ohno-Matsui,Jan E.E. Keunen,Reinier O. Schlingemann,Sobha Sivaprasad,Giuseppe Querques,Susan M. Downes,Sascha Fauser,Carel B. Hoyng,Felice Cardillo Piccolino,Jay Chhablani,Timothy Y Y Lai,Andrew J. Lotery,Michael Larsen,Frank G. Holz,K. Bailey Freund,Lawrence A. Yannuzzi,Camiel J. F. Boon,Camiel J. F. Boon +20 more
TL;DR: A comprehensive overview of the current rationale and evidence with respect to the variety of interventions available for treating central serous chorioretinopathy, including pharmacology, laser treatment, and photodynamic therapy is provided.
Journal ArticleDOI
Enhanced depth imaging optical coherence tomography in type 2 diabetes.
Giuseppe Querques,Rosangela Lattanzio,Lea Querques,Claudia Del Turco,Raimondo Forte,Luisa Pierro,Eric H Souied,Francesco Bandello +7 more
TL;DR: In diabetic eyes, there is an overall thinning of the choroid on EDI OCT, which may lead to tissue hypoxia and consequently increase the level of VEGF, resulting in the breakdown of the blood-retinal barrier and development of macular edema.
Journal ArticleDOI
Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy
Adriano Carnevali,Riccardo Sacconi,Riccardo Sacconi,Eleonora Corbelli,Livia Tomasso,Lea Querques,Gianpaolo Zerbini,Vincenzo Scorcia,Francesco Bandello,Giuseppe Querques +9 more
TL;DR: The ability of OCT-A to disclose early vascular alterations in patients with T1DM diagnosed as without any signs of DR on the basis of fundus biomicroscopy is demonstrated and results suggest that microvascular changes could precede detectable damage of diabetic neuroretinopathy.
Journal ArticleDOI
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial
Elon H. C. van Dijk,Sascha Fauser,Sascha Fauser,Myrte B. Breukink,Rocio Blanco-Garavito,Joannes M. M. Groenewoud,Jan E.E. Keunen,Petrus J.H. Peters,Greet Dijkman,Eric H Souied,Robert E MacLaren,Giuseppe Querques,Giuseppe Querques,Susan M. Downes,Carel B. Hoyng,Camiel J. F. Boon,Camiel J. F. Boon +16 more
TL;DR: Half-dose PDT is superior to HSML for treating patients with chronic central serous chorioretinopathy, leading to a significantly higher proportion of patients with complete resolution of SRF and functional improvement.